Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), announces Darren Head as Chief Executive Officer. Mr. Head’s previous leadership roles with Great Point Partners (“GPP”) investments include CEO positions at Bionova Scientific, MaSTherCell, and Cytovance Biologics in addition to multiple board member and CEO Advisory Board Member roles with GPP portfolio companies. In addition to Mr. Head’s CEO role, Cellipont announces a minority growth equity investment from HealthQuest Capital, a leading growth investor partnering with transformative healthcare companies. GPP, Cellipont’s majority investor, also participated in the growth equity investment.
Read the full article: Cellipont Bioservices Announces Minority Growth Equity Investment from HealthQuest Capital //
Source: https://www.businesswire.com/news/home/20241007351781/en/Cellipont-Bioservices-Announces-Darren-Head-As-Chief-Executive-Officer-Minority-Growth-Equity-Investment-From-HealthQuest-Capital